Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in the last 6 Months for AstraZeneca Canada Inc.

Gaby Bourbara, President (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results null-null of 21

  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director General, Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Martin Moen, Associate Assistant Deputy Minister | Global Affairs Canada (GAC)
    • Janice Charette, Chief Trade Negotiator to the US | Global Affairs Canada (GAC)

    Subject Matter of the communication: Government Procurement, Health, Industry, International Trade, Taxation and Finance, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-04-30
    Posted date: 2026-05-15
    Communication number: 15042-681725 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Elizabeth Wong, Senior Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)
    • Sony Perron, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)
    • Annahat Kochar, Senior Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    • Pamela Aung-Thin, Assistant Deputy Minister | Health Canada (HC)
    • Sara O'Connor, AADM, Regulatory Operations and Enforcement Brach | Health Canada (HC)
    • Celia Lourenco, AADM, Health Products and Food Branch | Health Canada (HC)
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Justine Frame, Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Science and Technology, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-04-29
    Posted date: 2026-05-15
    Communication number: 15042-681731 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director General, Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2026-04-24
    Posted date: 2026-05-15
    Communication number: 15042-681724 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justine Frame, Policy Advisor | Minister's Office | Health Canada (HC)
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2026-04-22
    Posted date: 2026-05-15
    Communication number: 15042-681722 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development, Economic Development
    Communication date: 2026-04-21
    Posted date: 2026-05-15
    Communication number: 15042-681721 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mackenzy Metcalfe, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Nasser Haidar, Senior Policy Advisor | Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Intergovernmental Affairs Secretariat (IGA)
    • Maggie Chi, Member of Parliament | House of Commons
    • Elizabeth Wong, Senior Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)
    • Annahat Kochar, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    • Shalene Curtis-Micallef, Deputy Minister | Deputy Minister's Office | Health Canada (HC)
    • Pamela Aung-Thin, Assistant Deputy Minister | Health Canada (HC)
    • Justine Frame, Policy Advisor | Minister's Office | Health Canada (HC)
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Jocelyne Voisin, Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-04-15
    Posted date: 2026-05-15
    Communication number: 15042-681735 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director General, Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Sony Perron, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Justine Frame, Policy Advisor | Minister's Office | Health Canada (HC)
    • Linsey Hollett, Assistant Deputy Minister | Health Canada (HC)
    • Jocelyne Voisin, Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)
    • Marjorie Michel, Minister of Health | Ministry of Health | Health Canada (HC)
    • Shalene Curtis-Micallef, Deputy Minister | Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2026-04-02
    Posted date: 2026-05-15
    Communication number: 15042-681728 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phillip Jennings, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Stephanie Tanton, Assistance Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2026-03-24
    Posted date: 2026-04-15
    Communication number: 15042-677423 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Moen, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
    Communication date: 2026-03-11
    Posted date: 2026-04-15
    Communication number: 15042-677045 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nasser Haidar, Senior Policy Advisor | Minister's Office | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Trade, Taxation and Finance, Research and Development, Economic Development
    Communication date: 2026-03-02
    Posted date: 2026-04-15
    Communication number: 15042-677420 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justine Frame, Special Assistant, Policy | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2026-02-25
    Posted date: 2026-03-16
    Communication number: 15042-671721 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maxence Toureche, Parliamentary Assistant | House of Commons
    • Maxime Blanchette-Joncas, Member of Parliament | House of Commons

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Taxation and Finance, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-02-25
    Posted date: 2026-03-16
    Communication number: 15042-671719 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nasser Haidar, Senior Policy Advisor | Office of the Min. responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy | Intergovernmental Affairs Secretariat (IGA)
    • Martin Moen, Associate Assistant Deputy Minister | Global Affairs Canada (GAC)
    • Ritu Banerjee, Assistant Deputy Minister | Office of Life Sciences and Manufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Manuela Tomic, Senior Policy Advisor | Minister of Industry and Minister Responsible for Canada Economic Development for Quebec Regions | Innovation, Science and Economic Development Canada (ISED)
    • Loris Mirella, Director, Intellectual Property, Trade Policy | Global Affairs Canada (GAC)
    • Dominic LeBlanc, President of the King's Privy Council for Canada and Minister of International Trade and Intergovernmental Affairs | Global Affairs Canada (GAC)
    • Janice Charette, Chief Trade Negotiator to the US | Global Affairs Canada (GAC)
    • Karim Bardeesy, Member of Parliament | House of Commons
    • Daniel MacDonald, Director General | Drugs for Rare Disease | Health Canada (HC)
    • Justine Frame, Special Assistant, Policy | Minister's Office | Health Canada (HC)
    • Sandenga Yeba, Director of Policy & Deputy Chief of Staff | Office of the Minister of Health | Health Canada (HC)
    • Shalene Curtis Micallef, Deputy Minister | Health Canada (HC)
    • Marjorie Michel, Minister of Health | Ministry of Health | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Taxation and Finance, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-02-23
    Posted date: 2026-03-16
    Communication number: 15042-671695 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Lacroix, Office Director | House of Commons
    • Linda Lapointe, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Taxation and Finance, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2026-02-13
    Posted date: 2026-03-27
    Communication number: 15042-675505 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bradley Bennet, Pharmacist | NIHB | Indigenous Services Canada (ISC)
    • Dylan Radke, Pharmacist | NIHB | Indigenous Services Canada (ISC)
    • Karen Fortin, Director, Pharmacy Benefits | NIHB | Indigenous Services Canada (ISC)
    • Mark Szeto, Policy Analyst | NIHB | Indigenous Services Canada (ISC)
    • Michelle Mujoombar, Manager | NIHB | Indigenous Services Canada (ISC)
    • Peter Berry, Senior Policy Analyst and Science Advisor | NIHB | Indigenous Services Canada (ISC)

    Subject Matter of the communication: Aboriginal Affairs, Government Procurement, Health, Industry, Intellectual Property, Research and Development, Economic Development, Federal-Provincial Relations
    Communication date: 2026-02-10
    Posted date: 2026-03-16
    Communication number: 15042-671559 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Paul-Hus, Member of Parlliament | House of Commons

    Subject Matter of the communication: Government Procurement, Health, Industry, International Trade, Taxation and Finance, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2026-02-06
    Posted date: 2026-03-16
    Communication number: 15042-671720 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hosai Zurmati Halim, Senior Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)
    • Elizabeth Wong, Senior Policy Advisor | Office of the President of the Treasury Board of Canada | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-04
    Posted date: 2026-01-15
    Communication number: 15042-665477 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nadeen Abd El Aal, Senior Policy Analyst | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director General, Health Emergency Readiness Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Government Procurement, Health, Industry, International Trade, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-04
    Posted date: 2026-01-15
    Communication number: 15042-665476 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maxime Pedneault, Senior Advisor | Health Canada (HC)
    • Pamela Aung-Thin, Assistant Deputy Minister | Health Canada (HC)
    • Jocelyne Voisin, Senior Assistant Deputy Minister | Health Policy Branch | Health Canada (HC)
    • Greg Orencsak, Former Deputy Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Budget, International Development, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-04
    Posted date: 2026-01-15
    Communication number: 15042-665475 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Senior Policy Advisor | Prime Minister's office | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-12-04
    Posted date: 2026-01-15
    Communication number: 15042-665474 View monthly communication report
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc-André Blanchard, Chief of Staff | Prime Minister's Office (PMO)
    • Shaili Patel, Deputy Director of Policy | Prime Minister's Office (PMO)
    • Alexandre Boulé, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Government Procurement, Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance, Budget, Research and Development, Economic Development, Federal-Provincial Relations, Foreign Affairs
    Communication date: 2025-11-21
    Posted date: 2025-12-15
    Communication number: 15042-662930 View monthly communication report
Date Modified: